Thy1mγSN transgenic mice have the mouse thymus cell antigen 1 (Thy-1) promoter directing expression of the mouse γ-synuclein (Sncg) gene. These mice may be useful for studying the pathophysiology of Parkinson's disease, and other neurodegenerative disorders.
Vladimir L Buchman, Cardiff University School of Biosciences
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence) |
Thy1mγSN transgenic mice have the mouse thymus cell antigen 1 (Thy-1) promoter directing expression of the mouse γ-synuclein (Sncg) gene. Homozygous Thy1mγSN mice are viable, fertile, and normal in size. They develop a clasping reflex, abnormal posture and gait, and other symptoms of motor dysfunction around 6 months of age, develop limb paralysis by 9 months of age, and die by 16 months of age. Homozygotes also show a 7-fold increase of γ-synuclein mRNA in neurons compared with wild-type mice, leading to motor neuron impairment and premature death. Hemizygous mice develop this phenotype starting at 12 months of age. γ-synuclein aggregates form fibrils, much like α-synuclein, aggregates of which have been associated with neurodegeneration in diseases such as Parkinson's disease. These mice may be useful for studying the pathophysiology of Parkinson's disease, and other neurodegenerative disorders.
The Thy1mγSN transgene was designed to contain the mouse γ-synuclein gene driven by a mouse thymus cell antigen 1 (Thy-1) promoter. The construct was microinjected into fertilized C57BL/6 oocytes. Animals from founder line HvP36 were bred to C57BL/6 mice to establish a colony of hemizygous Thy1mγSN mice. Upon arrival in the laboratory of Dr. Vladimir L. Buchman, these mice were backcrossed to C57BL/6J for 3 generations and were subsequently intercrossed for at least 7 generations to produce homozygotes. Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
Expressed Gene | Sncg, synuclein, gamma, mouse, laboratory |
---|---|
Site of Expression |
Allele Name | transgene insertion HvP36, Herman van der Putten |
---|---|
Allele Type | Transgenic (Inserted expressed sequence) |
Allele Synonym(s) | Thy1mgammaSN |
Gene Symbol and Name | Tg(Thy1-Sncg)HvP36Putt, transgene insertion HvP36, Herman van der Putten |
Gene Synonym(s) | |
Promoter | Thy1, thymus cell antigen 1, theta, mouse, laboratory |
Expressed Gene | Sncg, synuclein, gamma, mouse, laboratory |
Strain of Origin | C57BL/6 |
Chromosome | UN |
Molecular Note | The Thy1mgammaSN transgene was designed to contain the mouse gamma-synuclein gene driven by the neuron-specific mouse thymus cell antigen 1 (Thy-1) promoter. Founder line HvP36 was established. |
Mutations Made By | Herman van der Putten, Novartis |
When maintaining a live colony, heterozygous mice may be bred to wildtype (non-carriers) mice from the colony. Homozygous mice develop motor dysfunction by 6 months of age, limb paralysis by 9 months of age, and all die by 16 months of age.
When using the C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #012769 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous for Tg(Thy1-Sncg)HvP36Putt |
Frozen Mouse Embryo | C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J | $3373.50 |
Frozen Mouse Embryo | C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.